Early age at smoking initiation and tobacco carcinogen DNA damage in the lung

Journal of the National Cancer Institute

Volumn 91, Issue 7, 1999, Pages 614-619

  Wiencke, John K ^a   Thurston, Sally W ^b   Kelsey, Karl T ^b   Varkonyi, Andrea ^a   Wain, John C ^c   Mark, Eugene J ^c   Christiani, David C ^b,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER RISK; DNA DAMAGE; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG CARCINOGENESIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SMOKING; STATISTICAL ANALYSIS;

EID: 0033531652     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/91.7.614     Document Type: Article

References (38)

1. Wogan GN. Molecular epidemiology in cancer risk assessment and prevention: recent progress and avenues for future research. Environ Health Perspect 1992;98:167-78.
2. Schut HA, Shiverick KT. DNA adducts in humans as dosimeters of exposure to environmental, occupational, or dietary genotoxins. FASEB J 1992;6:2942-51.
3. Phillips DH, Hewer A, Martin CN, Garner RC, King MM. Correlation of DNA adduct levels in human lung with cigarette smoking. Nature 1988;336:790-2.
4. Randerath E, Miller RH, Mittal D, Avitts TA, Dunsford HA, Randerath K. Covalent DNA damage in tissues of cigarette smokers as determined by 32P-postlabeling assay. J Natl Cancer Inst 1989;81:341-7.
5. Garner RC, Cuzick J, Jenkins D, Phillips DH, Hewer A, King MM, et al. Linear relationship between DNA adducts in human lung and cigarette smoking. IARC Sci Publ 1990;104:421-6.
6. van Schooten FJ, Hillebrand MJ, van Leeuwen FE, Lutgerink JT, van Zandwijk N, Jansen HM, et al. Polycyclic aromatic hydrocarbon-DNA adducts in lung tissue from lung cancer patients. Carcinogenesis 1990;11: 1677-81.
7. 32P-postlabeling analysis of DNA from human tissues. Mutat Res 1992;282:139-45.
8. Weston A, Bowman ED, Shields PG, Trivers GE, Poirier MC, Santella RM, et al. Detection of polycyclic aromatic hydrocarbon-DNA adducts in human lung. Environ Health Perspect 1993;99:257-9.
9. Degawa M, Stern SJ, Martin MV, Guengerich FP, Fu PP, Ilett KF, et al. Metabolic activation and carcinogen-DNA adduct detection in human larynx. Cancer Res 1994;54:4915-9.
10. Shields PG, Bowman ED, Harrington AM, Doan VT, Weston A. Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes. Cancer Res 1993; 53:3486-92.
11. 32P-postlabeling: metabolic phenotype dependence and comparisons with other exposure markers. IARC Sci Publ 1993;124:331-40.
12. 32P-adduct assay. Carcinogenesis 1988;9:2309-13.
13. 32P-postlabeling analysis of DNA from exfoliated oral mucosa cells as a means of monitoring exposure of the oral cavity to genotoxic agents. Carcinogenesis 1989;10:1429-34.
14. Tang D, Santella RM, Blackwood AM, Young TL, Mayer J, Jaretzki A, et al. A molecular epidemiological case-control study of lung cancer. Cancer Epidemiol Biomarkers Prev 1995;4:341-6.
15. Denissenko MF, Pao A, Tang M, Pfeifer GP. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science 1996;274:430-2.
16. Denissenko MF, Chen JX, Tang MS, Pfeifer GP. Cytosine methylation determines hot spots of DNA damage in the human p53 gene. Proc Natl Acad Sci U S A 1997;94:3893-8.
17. Li D, Wang M, Cheng L, Spitz MR, Hittelman WN, Wei Q. In vitro induction of benzo(a)pyrene diol epoxide-DNA adducts in peripheral lymphocytes as a susceptibility marker for human lung cancer. Cancer Res 1996;56: 3638-41.
18. Rudiger HW, Nowak D, Hartmann K, Cerutti P. Enhanced formation of benzo(a)pyrene: DNA adducts in monocytes of patients with a presumed predisposition to lung cancer. Cancer Res 1985;45(11 Pt 2):5890-4.
19. Ryberg D, Hewer A, Phillips DH, Haugen A. Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. Cancer Res 1994;54:5801-3.
20. Kato S, Bowman ED, Harrington AM, Blomeke B, Shields PG. Human lung carcinogen-DNA adduct levels mediated by genetic polymorphisms in vivo [published erratum appears in J Natl Cancer Inst 1996;88:1595]. J Natl Cancer Inst 1995;87:902-7.
21. Phillips DH, Schoket B, Hewer A, Bailey E, Kostic S, Vincze I. Influence of cigarette smoking on the levels of DNA adducts in human bronchial epithelium and white blood cells. Int J Cancer 1990;46:569-75.
22. Talaska G, Jaeger M, Reilman R, Collins T, Warshawsky D. Chronic, topical exposure to benzo[a]pyrene induces relatively high steadystate levels of DNA adducts in target tissues and alters kinetics of adduct loss. Proc Natl Acad Sci U S A 1996;93:7789-93.
23. Wiencke JK, Kelsey KT, Varkonyi A, Semey K, Wain JC, Mark E, et al. Correlation of DNA adducts in blood mononuclear cells with tobacco carcinogen-induced damage in human lung. Cancer Res 1995;55:4910-4.
24. Becker RA, Chambers JM, Wilks AR. The new S language. Pacific Grove (CA): Wadsworth; 1988.
25. Lawless JF. Negative binomial and mixed Poisson regression. Can J Stat 1987;15: 209-25.
26. Piegorsch WW. Maximum likelihood estimation for the negative binomial dispersion parameter. Biometrics 1990;46:863-7.
27. Venables WN, Ripley BD. Modern applied statistics with S-Plus. New York (NY): Springer-Verlag; 1994.
28. McCullagh P, Nelder JA. Generalized linear models. 2nd ed. New York (NY): Chapman & Hall; 1989.
29. Lee JJ, Trizna Z, Hsu TC, Spitz MR, Hong WK. A statistical analysis of the reliability and classification error in application of the mutagen sensitivity assay. Cancer Epidemiol Biomarkers Prev 1996;5:191-7.
30. Hegmann KT, Fraser AM, Keaney RP, Moser SE, Nilasena DS, Sedlars M, et al. The effect of age at smoking initiation on lung cancer risk. Epidemiology 1993;4:444-8.
31. Doll R, Peto R. Mortality in relation to smoking: 20 years' observations on male British doctors. Br Med J 1976;2:1525-6.
32. Benhamou S, Benhamou E. The effect of age at smoking initiation on lung cancer risk [letter]. Epidemiology 1994;5:560-1.
33. Brauze D, Mikstacka R, Baer-Dubowska W. Formation and persistence of benzo[a]pyrene-DNA adducts in different tissues of C57BL/10 and DBA/2 mice. Carcinogenesis 1991;12:1607-11.
34. Boerrigter ME, Wei JY, Vijg J. Induction and repair of benzo[a]pyrene-DNA adducts in C57BL/6 and BALB/c mice: association with aging and longevity. Mech Ageing Dev 1995; 82:31-50.
35. Crawford FG, Mayer J, Santella RM, Cooper TB, Ottman R, Tsai WY, et al. Biomarkers of environmental tobacco smoke in preschool children and their mothers. J Natl Cancer Inst 1994;86:1398-402.
36. Perera FP, Whyatt RM, Jedrychowski W, Rauh V, Manchester D, Santella RM, et al. Recent developments in molecular epidemiology: a study of the effects of environmental polycyclic aromatic hydrocarbons on birth outcomes in Poland. Am J Epidemiol 1998;147:309-14.
37. Mooney LA, Santella RM, Covey L, Jeffrey AM, Bigbee W, Randall MC, et al. Decline of DNA damage and other biomarkers in peripheral blood following smoking cessation. Cancer Epidemiol Biomarkers Prev 1995;4: 627-34.
38. Dickey C, Santella RM, Hattis D, Tang D, Hsu Y, Cooper T, et al. Variability in PAH-DNA adduct measurements in peripheral mononuclear cells: implications for quantitative cancer risk assessment. Risk Anal 1997;17: 649-56.